These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8547217

  • 1. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype.
    Caulín C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M.
    Cell Growth Differ; 1995 Aug; 6(8):1027-35. PubMed ID: 8547217
    [Abstract] [Full Text] [Related]

  • 2. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.
    Frontelo P, González-Garrigues M, Vilaró S, Gamallo C, Fabra A, Quintanilla M.
    Exp Cell Res; 1998 Nov 01; 244(2):420-32. PubMed ID: 9806792
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
    Woodworth CD, Chung J, McMullin E, Plowman GD, Simpson S, Iglesias M.
    Cell Growth Differ; 1996 Jun 01; 7(6):811-20. PubMed ID: 8780894
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
    Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A.
    Cell Growth Differ; 1998 May 01; 9(5):393-404. PubMed ID: 9607560
    [Abstract] [Full Text] [Related]

  • 6. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
    Wilkins-Port CE, Higgins PJ.
    Cells Tissues Organs; 2007 May 01; 185(1-3):116-22. PubMed ID: 17587817
    [Abstract] [Full Text] [Related]

  • 7. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 8. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
    Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H, Shimizu K, Takehara K, Cano A, Saitoh M, Miyazono K.
    Cell Death Differ; 2004 Oct 15; 11(10):1092-101. PubMed ID: 15181457
    [Abstract] [Full Text] [Related]

  • 9. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
    Iglesias M, Frontelo P, Gamallo C, Quintanilla M.
    Oncogene; 2000 Aug 24; 19(36):4134-45. PubMed ID: 10962574
    [Abstract] [Full Text] [Related]

  • 10. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
    Kim ES, Kim MS, Moon A.
    Int J Oncol; 2004 Nov 24; 25(5):1375-82. PubMed ID: 15492828
    [Abstract] [Full Text] [Related]

  • 11. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.
    Caulín C, Bauluz C, Gandarillas A, Cano A, Quintanilla M.
    Exp Cell Res; 1993 Jan 24; 204(1):11-21. PubMed ID: 7677983
    [Abstract] [Full Text] [Related]

  • 12. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 13. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes.
    Santibañez JF.
    FEBS Lett; 2006 Oct 02; 580(22):5385-91. PubMed ID: 16989819
    [Abstract] [Full Text] [Related]

  • 14. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R.
    Nat Med; 2003 Jul 02; 9(7):964-8. PubMed ID: 12808448
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.
    Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T, Sawada N.
    Liver Int; 2008 Apr 02; 28(4):534-45. PubMed ID: 18031476
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K, Sheng H, Shao J, Beauchamp RD.
    Exp Cell Res; 2001 Jun 10; 266(2):239-49. PubMed ID: 11399052
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

  • 18. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
    Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M.
    Surgery; 2004 Aug 01; 136(2):364-74. PubMed ID: 15300203
    [Abstract] [Full Text] [Related]

  • 19. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L, Hill CS.
    Mol Cell Biol; 2005 Sep 01; 25(18):8108-25. PubMed ID: 16135802
    [Abstract] [Full Text] [Related]

  • 20. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
    Respir Res; 2005 Jun 09; 6(1):56. PubMed ID: 15946381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.